Show simple item record

dc.contributor.authorAltassan, R
dc.contributor.authorRadenkovic, S
dc.contributor.authorEdmondson, AC
dc.contributor.authorBarone, R
dc.contributor.authorBrasil, S
dc.contributor.authorCechova, A
dc.contributor.authorComan, D
dc.contributor.authorDonoghue, S
dc.contributor.authorFalkenstein, K
dc.contributor.authorFerreira, V
dc.contributor.authorFerreira, C
dc.contributor.authorFiumara, A
dc.contributor.authorFrancisco, R
dc.contributor.authorFreeze, H
dc.contributor.authoret al.
dc.date.accessioned2020-10-07T02:59:32Z
dc.date.available2020-10-07T02:59:32Z
dc.date.issued2020
dc.identifier.issn0141-8955
dc.identifier.doi10.1002/jimd.12286
dc.identifier.urihttp://hdl.handle.net/10072/398154
dc.description.abstractPhosphoglucomutase 1 (PGM1) deficiency is a rare genetic disorder that affects glycogen metabolism, glycolysis, and protein glycosylation. Previously known as GSD XIV, it was recently reclassified as a congenital disorder of glycosylation, PGM1‐CDG. PGM1‐CDG usually manifests as a multisystem disease. Most patients present as infants with cleft palate, liver function abnormalities and hypoglycemia, but some patients present in adulthood with isolated muscle involvement. Some patients develop life‐threatening cardiomyopathy. Unlike most other CDG, PGM1‐CDG has an effective treatment option, d‐galactose, which has been shown to improve many of the patients' symptoms. Therefore, early diagnosis and initiation of treatment for PGM1‐CDG patients are crucial decisions. In this article, our group of international experts suggests diagnostic, follow‐up, and management guidelines for PGM1‐CDG. These guidelines are based on the best available evidence‐based data and experts' opinions aiming to provide a practical resource for health care providers to facilitate successful diagnosis and optimal management of PGM1‐CDG patients.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofjournalJournal of Inherited Metabolic Disease
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchcode3202
dc.subject.keywordsd-galactose
dc.subject.keywordsPGM1-CDG
dc.subject.keywordscongenital disorder of glycosylation
dc.subject.keywordsmanagement guidelines
dc.subject.keywordsphosphoglucomutase 1 deficiency
dc.titleInternational consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationAltassan, R; Radenkovic, S; Edmondson, AC; Barone, R; Brasil, S; Cechova, A; Coman, D; Donoghue, S; Falkenstein, K; Ferreira, V; Ferreira, C; Fiumara, A; Francisco, R; Freeze, H; et al., International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management, Journal of Inherited Metabolic Disease, 2020
dcterms.dateAccepted2020-07-14
dc.date.updated2020-10-07T02:16:50Z
gro.hasfulltextNo Full Text
gro.griffith.authorComan, Dave J.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record